A5005974473- Pulmonary Hypertension Research and Treatments
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Cardiac pacing and defibrillation studies
- Obstructive Sleep Apnea Research
- Cardiovascular Issues in Pregnancy
- Cardiomyopathy and Myosin Studies
- Systemic Sclerosis and Related Diseases
- Health Systems, Economic Evaluations, Quality of Life
- Medication Adherence and Compliance
- Cardiac electrophysiology and arrhythmias
- Respiratory Support and Mechanisms
- Congenital heart defects research
- Mitochondrial Function and Pathology
- Neuroscience of respiration and sleep
- Coronary Interventions and Diagnostics
- Heart rate and cardiovascular health
- Mechanical Circulatory Support Devices
- Cardiovascular and Diving-Related Complications
- Hemodynamic Monitoring and Therapy
- Pharmaceutical Economics and Policy
- Connective Tissue Growth Factor Research
- Congenital Heart Disease Studies
- Nitric Oxide and Endothelin Effects
- Neurofibromatosis and Schwannoma Cases
University of Foggia
2015-2020
Percutaneous coronary intervention (PCI) has significantly improved the management of ischemic heart disease, particularly with advent drug-eluting stents (DES), which have substantially lowered incidence stent thrombosis compared to bare-metal (BMS). Despite this progress, complications such as thrombosis, though less frequent, remain clinically relevant. From a pharmacological perspective, dual antiplatelet therapy (DAPT) plays an essential role in minimizing risk albeit at cost increased...
Aim of this study was to assess the impact introduction new class drugs (ARNI: angiotensin receptor-neprilysin inhibitor) on hospital related costs in a real world cohort patients with chronic heart failure (CHF).Seventy-three consecutive CHF and systolic dysfunction eligible for treatment ARNIs from Daunia Heart Failure Registry were enrolled. Incidence hospitalizations before after ARNI, drug hospitalization HF recorded, indexed per year compared.Indexed mean number 0.93 ± 1.70 0.19 0.70...
Right heart catheterization (RHC) is recommended by guidelines for the diagnosis of pulmonary hypertension, definition hemodynamic impairment and responsiveness to drug therapy. However, RHC an invasive test with associated risk complications. Noninvasive echocardiographic tools, possibly predictive hypertension at RHC, could be therefore extremely useful.Sixty-four consecutive patients suspected were enrolled in study assessed echocardiography RHC. Diagnosis was based on mean artery...
Abstract Background Right heart catheterization ( RHC ) is usually required to confirm the diagnosis of pulmonary artery hypertension PAH ). As an invasive test, may be associated with possible complications, so noninvasive parameters able predict at would extremely useful. Aim To ascertain correlations between cardiopulmonary exercise testing CPET and hemodynamic indicative PH Methods Thirty‐six consecutive outpatients suspect underwent ; intercept ventilation (VEint) on VE vs carbon...
Several cardiopulmonary exercise test (CPET) parameters (peak VO
Tissue Doppler imaging (TDI) is used to improve risk stratification in patients with chronic heart failure (CHF). So far, few studies have this method investigate the characteristics of subjects CHF and Cheyne-Stokes breathing (CSB). The aim study was therefore evaluate whether TDI assessment may predict presence CSB CHF.A total 41 consecutive enrolled Daunia Heart Failure Registry underwent echocardiography nocturnal polygraphy sleep apnea CSB. Conventional parameters were calculated. We...